Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
boston top stories
clinical trials
gene editing
2
×
life sciences
2
×
national blog main
2
×
allergan
american society of clinical oncology (asco)
anti-inflammatory drugs
arcturus therapeutics
avrobio
boston
boulder/denver blog main
boulder/denver top stories
brexanolone
camp4 therapeutics
cancer
cancer immunotherapy
crispr
crispr therapeutics
crispr-cas9
cynthia collins
deals
denali therapeutics
detroit blog main
detroit top stories
drugs
editas medicine
eidos therapeutics
estradiol
f-star gamma
fda
food and drug administration
genmab
ido inhibitors
incyte
indiana blog main
indiana top stories
investing
What
clinical
2
×
ahead
allergan
ambien
american
annual
asco
attendees
attention
biotech
blessing
bosley
camp’s
cancer
cash
ceo
check
chicago
city
combinations
community’s
crispr
cusp
days
depart
drug
editas
editing
expanding
experimental
focus
gene
home
humans
katrine
key
kicks
medicine
meeting
million
Language
Current search:
biotech
×
clinical
×
" life sciences "
×
" national blog main "
×
" gene editing "
×
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More